+499.5%
MRNA vs SPXL
+52.0%
+447.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPXL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.2% | -1.0% | -1.5% |
| 7D | +5.5% | +0.1% | +5.4% | +5.2% |
| 30D | +158.7% | -0.9% | +159.6% | +161.6% |
| 3M | +182.1% | +2.0% | +180.1% | +179.5% |
| 6M | +151.8% | +33.5% | +118.3% | +113.1% |
| YTD | +393.6% | +32.2% | +361.4% | +315.6% |
| 1Y | +499.5% | +48.9% | +450.6% | +334.2% |
| All | +499.5% | +52.0% | +447.5% | +334.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXL.
Daily Out/Under-Performance
Portfolio return minus SPXL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPXL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling